Guohong Li

449 total citations
23 papers, 348 citations indexed

About

Guohong Li is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Guohong Li has authored 23 papers receiving a total of 348 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Oncology, 6 papers in Surgery and 5 papers in Epidemiology. Recurrent topics in Guohong Li's work include Lung Cancer Diagnosis and Treatment (3 papers), Medical Imaging Techniques and Applications (2 papers) and IgG4-Related and Inflammatory Diseases (2 papers). Guohong Li is often cited by papers focused on Lung Cancer Diagnosis and Treatment (3 papers), Medical Imaging Techniques and Applications (2 papers) and IgG4-Related and Inflammatory Diseases (2 papers). Guohong Li collaborates with scholars based in China, United States and Sweden. Guohong Li's co-authors include Ian J. Sarembock, Klaus Ley, John M. Sanders, Elena Galkina, Melissa Bevard, Rong Jin, Weidong Zhang, Zhihui Zhong, Fei Gao and Rui Zhong and has published in prestigious journals such as Journal of Clinical Oncology, Journal of the American College of Cardiology and PLoS ONE.

In The Last Decade

Guohong Li

22 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Guohong Li China 12 81 72 61 52 49 23 348
Geun-Young Kim South Korea 8 45 0.6× 93 1.3× 114 1.9× 27 0.5× 36 0.7× 11 355
Kenji Bannai Japan 7 110 1.4× 78 1.1× 122 2.0× 27 0.5× 22 0.4× 12 378
Jietao Lin China 12 96 1.2× 59 0.8× 136 2.2× 42 0.8× 54 1.1× 39 380
Hitoshi Teraoka Japan 9 125 1.5× 129 1.8× 141 2.3× 61 1.2× 28 0.6× 40 518
Monika Philipp Germany 11 86 1.1× 100 1.4× 127 2.1× 97 1.9× 77 1.6× 14 577
Fabio Ferrando Italy 12 161 2.0× 86 1.2× 104 1.7× 44 0.8× 29 0.6× 23 398
Tamara Djurić Serbia 13 85 1.0× 98 1.4× 134 2.2× 36 0.7× 43 0.9× 52 409
Selin Gencer Germany 10 78 1.0× 170 2.4× 132 2.2× 71 1.4× 33 0.7× 14 375
H. Hassan Egypt 10 138 1.7× 162 2.3× 147 2.4× 59 1.1× 36 0.7× 22 547

Countries citing papers authored by Guohong Li

Since Specialization
Citations

This map shows the geographic impact of Guohong Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guohong Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guohong Li more than expected).

Fields of papers citing papers by Guohong Li

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guohong Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guohong Li. The network helps show where Guohong Li may publish in the future.

Co-authorship network of co-authors of Guohong Li

This figure shows the co-authorship network connecting the top 25 collaborators of Guohong Li. A scholar is included among the top collaborators of Guohong Li based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guohong Li. Guohong Li is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jin, Zhaohui, Min Sun, Huiling Yang, et al.. (2024). Targeted tilianin lipid nanoparticles for the treatment of atherosclerosis through remodeling lesional macrophage phenotype. Nano Research. 18(2). 94907144–94907144. 1 indexed citations
2.
Lin, Zhipeng, Zhihao Wang, Jin-Li Guo, et al.. (2024). The recombinant vaccine of Lactobacillus plantarum elicits immune protection against H1N1 and H9N2 influenza virus infection. International Journal of Biological Macromolecules. 275(Pt 1). 133453–133453. 1 indexed citations
3.
Li, Guohong, et al.. (2023). TACE Combined with Lenvatinib and Camrelizumab for Unresectable Multiple Nodular and Large Hepatocellular Carcinoma (>5 cm). Technology in Cancer Research & Treatment. 22. 2223942208–2223942208. 12 indexed citations
4.
Wu, Di, Yong Li, Pengfei Xu, et al.. (2023). A pilot phase II trial of neoadjuvant camrelizumab plus nab-paclitaxel and cisplatin (NeoCPC) for locoregionally advanced, resectable squamous cell carcinoma of the head and neck.. Journal of Clinical Oncology. 41(16_suppl). 6069–6069. 1 indexed citations
5.
Han, Li, Xinran Wu, Ou Wang, et al.. (2023). Mesenchymal stromal cells and alpha-1 antitrypsin have a strong synergy in modulating inflammation and its resolution. Theranostics. 13(9). 2843–2862. 8 indexed citations
7.
Jin, Rong, et al.. (2019). EPPS treatment attenuates traumatic brain injury in mice by reducing Aβ burden and ameliorating neuronal autophagic flux. Experimental Neurology. 314. 20–33. 15 indexed citations
8.
Li, Guohong, et al.. (2019). Safety and efficacy of 125I brachytherapy for bilateral lung recurrences from hepatocellular carcinoma after resection or ablation. Journal of Cancer Research and Clinical Oncology. 145(7). 1907–1916. 10 indexed citations
9.
Wang, Xinhua, et al.. (2016). Prognostic Significance of Serum CD26 Concentration in Patients with Esophageal Squamous Cell Carcinoma. Archives of Medical Research. 47(4). 299–303. 6 indexed citations
10.
Wang, Xin, et al.. (2016). A new compound from Stereum insigne CGMCC5.57. Natural Product Research. 31(8). 932–937. 12 indexed citations
11.
Li, Wenjuan, Chunjing Zhang, Hongyan Du, et al.. (2015). Withaferin A suppresses the up‐regulation of acetyl‐coA carboxylase 1 and skin tumor formation in a skin carcinogenesis mouse model. Molecular Carcinogenesis. 55(11). 1739–1746. 37 indexed citations
12.
Li, Guohong, et al.. (2015). 125I Brachytherapy in Locally Advanced Nonsmall Cell Lung Cancer After Progression of Concurrent Radiochemotherapy. Medicine. 94(49). e2249–e2249. 26 indexed citations
13.
Li, Weimin, et al.. (2015). Association between red cell distribution width and the risk of heart events in patients with coronary artery disease. Experimental and Therapeutic Medicine. 9(4). 1508–1514. 16 indexed citations
14.
Wang, Cuiping, Rong Jin, Anil Nanda, Jinchuan Yan, & Guohong Li. (2015). Platelet PI3Kγ Contributes to Carotid Intima-Media Thickening under Severely Reduced Flow Conditions. PLoS ONE. 10(6). e0129265–e0129265. 6 indexed citations
15.
Chen, Baoan, et al.. (2014). The interference in the suicide ideation of patients with malignant tumors by mental clinical nursing pathway. Patient Preference and Adherence. 8. 1665–1665. 5 indexed citations
16.
Jiang, Xinhua, Haoming Song, Qingyu Liu, et al.. (2014). Castleman disease of the neck: CT and MR imaging findings. European Journal of Radiology. 83(11). 2041–2050. 16 indexed citations
17.
Li, Zhenmei, et al.. (2014). R237 and H238 Are Key Amino Acids in the Rubella Virus E1 Neutralization Epitope. Viral Immunology. 27(9). 422–429. 2 indexed citations
18.
Li, Guohong, John M. Sanders, Melissa Bevard, et al.. (2008). CD40 Ligand Promotes Mac-1 Expression, Leukocyte Recruitment, and Neointima Formation after Vascular Injury. American Journal Of Pathology. 172(4). 1141–1152. 89 indexed citations
19.
Dong, Jinyan, Wei Zhou, Lei Li, et al.. (2006). A New Epidithiodioxopiperazine Metabolite Isolated from Gliocladium roseum YMF1.00133. Chinese Chemical Letters. 17(7). 922–924. 13 indexed citations
20.
Li, Guohong, David Wang, Yiu-Fai Chen, & Suzanne Oparil. (2003). Vascular injury induces expression of periostin: A novel vascular extracellular matrix protein via the P13-kinase-MAP kinase pathway. Journal of the American College of Cardiology. 41(6). 34–34. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026